Medicinova (MNOV) Accumulated Depreciation (2011 - 2025)
Medicinova's (MNOV) quarterly Accumulated Depreciation came in at $422809.0 in Q4 2025, up 4.98% year-on-year from $402734.0 in Q4 2024, and up 4.98% on a QoQ basis from $402734.0 in Q4 2024.
Medicinova (MNOV) Accumulated Depreciation (2011 - 2025) Analysis & Trends
Medicinova (MNOV) has 15 years of Accumulated Depreciation data on file, last reported at $422809.0 in Q4 2025.
- On a quarterly basis, Accumulated Depreciation rose 4.98% year-over-year to $422809.0 in Q4 2025; TTM through Dec 2025 was $422809.0, a 4.98% increase from a year earlier, with the FY2025 full-year figure at $422809.0, up 4.98% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $422809.0, up from $402734.0 in the prior quarter.
- Over the last five years, Accumulated Depreciation for MNOV reached as high as $443513.0 in Q4 2023 and fell as low as $402734.0 in Q4 2024.
- Historically, Accumulated Depreciation has averaged $425411.8 across 5 years, with a median of $425203.0 in 2021.
- Across the five-year window, Accumulated Depreciation declined 18.8% in 2021 and rose 4.98% in 2025, its largest moves.
- Year by year, Accumulated Depreciation stood at $425203.0 in 2021, then rose by 1.79% to $432800.0 in 2022, then grew by 2.48% to $443513.0 in 2023, then declined by 9.19% to $402734.0 in 2024, then gained by 4.98% to $422809.0 in 2025.
- Per Business Quant data, the three most recent Accumulated Depreciation figures were $422809.0 in Q4 2025, $402734.0 in Q4 2024, and $443513.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 422,809.00 |
| Dec 31, 2024 | 402,734.00 |
| Dec 31, 2023 | 443,513.00 |
| Dec 31, 2022 | 432,800.00 |
| Dec 31, 2021 | 425,203.00 |
| Dec 31, 2020 | 523,617.00 |
| Dec 31, 2019 | 497,859.00 |
| Dec 31, 2018 | 483,528.00 |
| Dec 31, 2017 | 471,715.00 |
| Dec 31, 2016 | 499,400.00 |
| Dec 31, 2015 | 483,242.00 |
| Dec 31, 2014 | 461,948.00 |
| Dec 31, 2013 | 431,193.00 |
| Dec 31, 2012 | 672,301.00 |
| Dec 31, 2011 | 925,935.00 |